Showing Results for
From:Pediatric Nephrology (Vol. 30, Issue 8) Peer-ReviewedBackground Rituximab (RTX) has recently been introduced as a second-line therapy for nephrotic syndrome in children. Studies show that RTX given during the nephrotic state may be less effective than treatment during...
From:Clinical Pharmacokinetics (Vol. 54, Issue 4) Peer-ReviewedCitation Only
Choose how you want to be alerted when new results for your search become available.
Subscribe to Gale's RSS feed to get content delivered to your favorite RSS aggregator. Copy and paste the URL below into your reader:
Tell us where to send the alert and how often you want to receive it